In the new study, by the University of Exeter and Fishtek Marine, pots fitted with LEDs caught up to 19 times more northern shrimp than unlit pots. Importantly, illuminated pots also attracted fish -- ...

An edible robot leverages a combination of biodegradable fuel and surface tension to zip around the water's surface, creating a safe -- and nutritious -- alternative to environmental monitoring ...

Exposure to thiamethoxam, a neonicotinoid insecticide, causes a myriad of health effects in fish that can then impact humans ...

During a live event, Daniel M. Geynisman, MD, and participants discussed which efficacy end points they value and how they ...

Communities that rely on fishing for food, business, or cultural traditions are especially vulnerable. Health officials issue ...

A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown ...

Building on this foundation, we developed a multimodal deep learning approach that combines H&E histology with RNA FISH data to enhance prognostic accuracy in breast cancer. To integrate both ...

A groundbreaking new study from Japan suggests that one simple dietary choice – eating small fish whole – might significantly reduce cancer mortality risk, particularly for women. A team of ...

Papillary renal cell carcinoma is a type of kidney cancer. The kidneys are two small organs that work to remove waste products from the blood. Papillary renal cell carcinoma (PRCC) forms in the cells ...

Ki-67 is a protein found in the nucleus of cancer cells that are actively growing and dividing. For breast cancer, Ki-67 is one of the main tumor biomarkers that your healthcare provider will check ...

Health experts at the NHS have warned that a common symptom experienced after eating could be the “least-recognised” sign of cancer. They explained that 79% of Brits would not realise this ...

Analysts forecast that Lenvima could eventually exceed annual sales of $1bn, and the new approval in RCC - the most common form of kidney cancer - will be a major component of that growth.